Judges
are now being recruited for the 2010
Connecticut Science Fair more
|
|
|
Nominations
for 2010 Connecticut Medal of Technology
are due March 1 more
|
|
|
Affomix
Corporation has an opening in Branford for
a Research Associate more
|
|
|
Events Column |
|
|
2/9 4:30 -
5:30 pm
Book presentation by authors of "From Innovation to Cash
Flows." Hosted by Yale Entrepreneurial Institute and
Withers Bergman LLP. Yale Book Store, 77 Broadway, New Haven. more
|
|
|
2/10 5:00 pm -
7:30 pm
MIT Enterprise Forum of CT: "Concept Clinic for Earth
Markets." New Haven Lawn Club, 193 Whitney Avenue, New
Haven. more
|
|
|
2/23 6:00 pm -
9:00 pm
CT LES Chapter: Being Green: Tours of Kroon Hall and
Presentation on "Climate Change, Cleantech and
Licensing." Bowers Auditorium, Sage Hall, Yale School of
Forestry & Environmental Studies, 205 Prospect Street, New
Haven. more
|
|
|
2/25 4:00 pm - 6:00 pm
CURE/Yale BioHaven Entrepreneurship Series: Arbor Fuel. Kline
Geology Lab Building, Yale University, 210 Whitney Avenue, New
Haven. more
|
|
|
|
3/1 Nominations
due for 2010 Connecticut Medal of Technology more
|
|
|
|
3/9-3/13
2010 Connecticut Science Fair. Quinnipiac University, Hamden more
|
|
|
|
3/10
MIT Enterprise Forum of CT more
|
|
|
3/11
4:00 pm - 6:00pm
CURE/Yale BioHaven
Entrepreneurship Series: Jonathan Rothberg. Anlyan Center,
Yale Medical School, New Haven. more
|
|
|
|
4/7
MIT Enterprise Forum of CT more
|
|
|
4/8
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: Amarin Pharma Inc. Anlyan Center,
Yale Medical School, New Haven. more
|
|
|
|
5/5
MIT Enterprise Forum of CT more
|
|
|
|
4/20-23
2010 National SBIR
Conference. Connecticut Convention Center, 100 Columbus
Boulevard, Hartford. more
|
|
|
4/21
7:30 am - 5:15 pm
Yale CME Conference: "Sexuality and Cancer Survivorhip."
New Haven Lawn Club, 193 Whitney Avenue, New Haven more
|
|
|
5/12
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: JS Genetics. Anlyan Center, Yale
Medical School, New Haven. more
|
|
|
5/26
4:00 pm - 6:00 pm
CURE/Yale BioHaven
Entrepreneurship Series: Kolltan Pharmaceuticals. Anlyan
Center, Yale Medical School, New Haven. more
|
|
|
|
|
Biopharmas Need Investment and Investors Need Clarity
From the desk of Paul
Pescatello, President and CEO of CURE
 The
mood at the recent JP Morgan Healthcare conference was notably more upbeat than a year ago, but still muted compared to the not-so-distant past.
Uncertainty confronts the industry on at least three fronts. First is the utility and efficiency of the biopharma business model.
Overlaying a reassessment of the biopharma business model is an uncommonly deep and coordinated recession.
A final thick stratum of uncertainty is healthcare reform.
For the full story |
|
|
Rib-X Founder
Steitz Gives Nobel Lecture in New Haven
 Thomas
Steitz, Ph.D., a founder of New Haven's Rib-X Pharmaceuticals as well as Sterling professor of molecular biophysics and biochemistry and professor of chemistry at Yale University, on January 13
presented his Nobel Lecture for a local audience. The lecture,
From the Structure and Function of the Ribosome to New
Antibiotics, was first delivered at Stockholm University last December, two days before Professor Steitz received the Nobel Prize in chemistry.
For the full story
|
|
|
Rib-X, HistoRx, Affomix Draw 4Q Venture Capital
Some 55% of the venture capital
invested in Connecticut in the fourth quarter of 2009 was in
the life sciences area, according to The
MoneyTreeŽ Report, issued quarterly by PricewaterhouseCoopers
and the National Venture Capital Association, based on data
from Thomson Reuters.
For the full story
|
|
|
Long Wharf
Hosts Forum on Alzheimer's Disease
Health leaders from across the country took part in a day-long global health discussion at Long Wharf Theater in New Haven January 29 devoted to Alzheimer's Disease, part of the Global Health & The Arts series. In addition to hearing from speakers on the scientific and human issues involved in the disease, the audience saw a performance of
Lil's 90th, a new play about a family dealing with the mental decline of its patriarch.
For the full story
|
|
|
Study
Highlights CT Biotechs' Emphasis on Orphan Drugs
Several pharmaceutical companies with operations in
Connecticut are focusing more on research
into treatments for rare diseases, according to a
study released by the Tufts Center for the Study of Drug
Development.
For the full story
|
|
|
Study Shows
CI Investments Grow CT Economy
A
new study shows consistent contributions to the state's economy
of both jobs and revenues resulting from CI investments.
"Emerging technologies such as bioscience, life
sciences and clean tech are among the fastest-growing
business sectors in the country, and CI has placed
Connecticut at the forefront of these industries," said
Governor M. Jodi Rell.
For the full story
|
|
|
Medal of
Technology Nominations Now Open
Nominations for the 2010 Connecticut Medal of Technology are due on March 1, 2010 by 4:00 p.m. The Medal of Technology is Connecticut's highest honor for technological achievement in fields crucial to Connecticut's economic competitiveness. Modeled after the National Medal of Technology and Innovation, this award is bestowed by the Governor in alternate years with the Connecticut Medal of Science.
For the full story
|
|
|
Connecticut
Stem Cell Research Roundup
Connecticut
– the stem cell state
U.S. Rep.
Christopher Murphy urged Gov. M. Jodi Rell and legislative
leaders to reject a proposal to eliminate $10 million in
stem cell research funding for 2010. In a conference call
with stem cell researchers and reporters, Murphy
said that Connecticut has laid the groundwork to be a leader
in stem cell research.
For the full story |
CURE Member News Digest
 454
Life Sciences announces GS Junior system
Achillion moving forward to proof
of concept
Affomix signs deals with Millipore,
Kalgene
Alexion names William Keller to
Board of Directors
Amarin top-performing stock in
2009
Applied Spine receives new patent
Boehringer Ingelheim wins SPIRIVAŽ
support from FDA
Bristol-Myers Squibb completes Mead Johnson
deal
Cantor Colburn attorney named to
trademark post
Cara Therapeutics featured in Danbury
News-Times story
Connecticut Innovations invest more
in Helix Therapeutics
Genomas featured in Hartford
Business Journal story
GlaxoSmithKline in VireadŽ
agreement with Gilead
Hartford Hospital introduces
high-tech gown
Helix Therapeutics gets more
venture capital funding
HistoRx has license for Yale
diagnostic tool
Ipsogen expands leukemia
diagnostics offer
Johnson
& Johnson reports INVEGAŽ data
MannKind facility
in Danbury wins awards
Marinus names George Horner of
Sofinnova to Board
Pfizer reports
GeodonŽ approval
PhRMA
issues
statement on health care reform
Quinnipiac
University
plans medical school
Rib-X inks agreement with Mass
General
SBIR-CT to host national convention
in Hartford
UConn team develops
biosensor
Yale synthetic molecules
enhance HIV immune response
For
the full story |
|
